StonvexLoading…
StonvexStonvexStonvexCore line items from MG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $724.02M | $729.64M | $705.47M | $179.35M |
Operating Income | $40.57M | $39.83M | $-1.90M | $-4.68M |
Net Income | $16.84M | $18.96M | $-17.45M | $-10.30M |
EPS (Diluted) | $0.53 | $0.60 | $-0.58 | $-0.34 |
Total Assets | $578.78M | $523.04M | $534.78M | Not available |
Total Liabilities | $343.14M | $324.14M | $344.27M | Not available |
Cash & Equivalents | $28.01M | $18.32M | $17.65M | Not available |
Free Cash Flow OCF − CapEx | $8.31M | $32.23M | $5.89M | Not available |
Shares Outstanding | 32.06M | 31.61M | 30.33M | Not available |